View in EDS

Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance.

Saved in:
Bibliographic Details
Title: Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance.
Authors: Alsugair AKA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Mangaonkar A; Division of Hematology, Mayo Clinic, Rochester, MN, USA. mangaonkar.abhishek@mayo.edu.
Source: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2025 Sep 26; Vol. 20 (1), pp. 11. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41003858
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alsugair+AKA%22">Alsugair AKA</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Mangaonkar+A%22">Mangaonkar A</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA. mangaonkar.abhishek@mayo.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101262565%22">Current hematologic malignancy reports</searchLink> [Curr Hematol Malig Rep] 2025 Sep 26; Vol. 20 (1), pp. 11. <i>Date of Electronic Publication: </i>2025 Sep 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%22">Current Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101262565 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-822X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215588211%22">15588211 </searchLink><i>NLM ISO Abbreviation: </i>Curr Hematol Malig Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41003858
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11899-025-00757-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 11
    Titles:
      – TitleFull: Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alsugair AKA
      – PersonEntity:
          Name:
            NameFull: Mangaonkar A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 09
              Text: 2025 Sep 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1558-822X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Current hematologic malignancy reports
              Type: main
ResultId 1